Key facts today
Eli Lilly's shares rose following positive trial results for its weight-loss drug, Orforglipron, as analysts at Cantor Fitzgerald gave it an Overweight rating, noting its strong market position.
200 ARS
9.70 T ARS
41.24 T ARS
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFTQS8
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
LLY possible buy trend This chart highlights a recent price breakout followed by a pullback into consolidation.
Key indicators in play:
✅ EMA 9/20/56: Price is currently trading below all EMAs, showing fading momentum. The EMAs are curling down, suggesting short-term weakness or cooling after a strong move.
🟣 SMA 50 & 2
Eli Lilly: Catch the Knife or Wait for Support?LLY Just Dropped — Opportunity or Trap?
🔥 LLY (Eli Lilly) is on every trader’s radar! With biotech momentum and blockbuster drug potential, this stock is ready to rip once the dust settles. Smart money is eyeing key zones for a golden entry. 💊📈
📉 New Entry Zones:
🔥 630.00 – Solid buy level
🔥 550.0
ELI LILLY: The time to buy and target 1,300 is now.Eli Lilly is neutral on its 1D technical outlook (RSI = 48.409, MACD = -5.160, ADX = 28.927) and this is technically the most efficient level to buy for the long term towards the end of the year, as the price is sitting around its 1W MA50. The macro pattern is a Channel Up starting back in March 201
Eli Lilly Hit Resistance. LLYMy last idea on LLY proved to be very profitable, so here are the early signs of a pivot at hand. Technically, the indicators flipped almost in unison, MIDAS crossed. And just look at that fat bearish candle setting the tone. It is this constellation of factors that gives one confidence to profit fr
$LLY Long-Term BuyHealthcare could possibly be the next rotation coming out of this tech bull run. Using the Trade Jeanie (Jeanius Screener/Indicator), I was able to see the current technical buy signals happening on NYSE:LLY :
Inside a HTF fair value gap (3M timeframe)
Took out an untested low (liquidity)
LLY: Strong Buy in My Radar List - Feb. 26Technical Analysis (TA) & Price Action
Eli Lilly (LLY) is showing strong bullish momentum, currently trading within an ascending channel on the 1-hour timeframe. The stock recently tested the upper trendline and is consolidating near $900, a key psychological level.
Key observations:
* Trend Struc
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS238628644
ELI LILLY 21/43Yield to maturity
8.02%
Maturity date
Sep 14, 2043
US532457BZ0
ELI LILLY 20/60Yield to maturity
7.49%
Maturity date
Sep 15, 2060
US532457BY3
ELI LILLY 20/50Yield to maturity
7.39%
Maturity date
May 15, 2050
US532457BT4
ELI LILLY 19/49Yield to maturity
6.45%
Maturity date
Mar 15, 2049
US532457BU1
ELI LILLY 19/59Yield to maturity
6.37%
Maturity date
Mar 15, 2059
US532457BS6
ELI LILLY 19/39Yield to maturity
6.16%
Maturity date
Mar 15, 2039
LLYC
ELI LILLY 15/25Yield to maturity
6.15%
Maturity date
Jun 1, 2025
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045Yield to maturity
6.11%
Maturity date
Mar 1, 2045
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
6.10%
Maturity date
Feb 27, 2063
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
6.08%
Maturity date
May 15, 2047
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064Yield to maturity
6.05%
Maturity date
Feb 9, 2064
See all LLY bonds
Curated watchlists where LLY is featured.